Causes
Fibrodysplasia ossificans progressiva is caused by a specific mutation in the ACVR1 gene. This gene provides instructions for producing a receptor involved in the body's growth and development, specifically relating to bone and cartilage. The mutation causes the receptor to become overactive, triggering the transformation of soft tissue into bone (heterotopic ossification) when it should not. While this condition is inherited in an autosomal dominant pattern, meaning one copy of the altered gene is sufficient to cause the disorder, most cases result from a new, spontaneous gene mutation in individuals with no family history of the disease.

Risk Factors and Triggers
Since the primary cause is genetic, the main risk factor is carrying the specific gene mutation. However, for individuals who have the condition, certain environmental factors can trigger rapid progression or "flare-ups" of bone growth. These triggers often include:

• Soft tissue trauma, such as bumps, bruises, or falls.
• Intramuscular injections, including vaccines administered into the muscle.
• Surgeries, biopsies, or invasive dental work.
• Viral illnesses like the flu.
• Muscle overexertion or fatigue.

Prevention
There is currently no way to prevent the underlying genetic mutation that causes the disease. Primary prevention strategies focus entirely on avoiding events that trigger flare-ups and accelerated bone formation. Patients are advised to avoid contact sports, prevent falls, and decline intramuscular injections or unnecessary surgical procedures. Biopsies are particularly dangerous as they invariably cause rapid bone growth at the site and should be avoided if FOP is suspected.

Signs and Symptoms
The most characteristic early sign of fibrodysplasia ossificans progressiva, present at birth, is a malformation of the big toes, which are typically short and bent inward (hallux valgus). During early childhood, usually starting before age 10, children experience painful swellings in the neck, shoulders, and back. These flare-ups may look like tumors but are actually inflammation that precedes the formation of new bone. Over time, the condition causes progressive stiffness and locking of joints. The pattern of bone formation generally follows a specific direction: from the head and neck down to the spine and pelvis, and from the trunk outward to the arms and legs. Other symptoms may include difficulty moving the neck, limited arm motion, and eventually, a fused jaw or spine.

Diagnosis
Clinicians typically identify FOP through a physical examination that reveals the characteristic big toe malformations and the presence of soft tissue swellings or unexplained bone growth. Standard imaging tests like X-rays can confirm the presence of heterotopic bone and skeletal abnormalities, although early soft tissue flare-ups might be evaluated with other scans. A definitive diagnosis is made using genetic testing to confirm the ACVR1 mutation. It is critical that doctors recognize the clinical signs—specifically the toes—before ordering invasive tests.

Differential Diagnosis
Because FOP is extremely rare, it is frequently misdiagnosed as cancer (sarcoma), aggressive juvenile fibromatosis, or osseous heteroplasia. Misdiagnosis is dangerous because it often leads to biopsies, which are harmful triggers that cause the condition to worsen rapidly.

Medical Management
Treatment for fibrodysplasia ossificans progressiva focuses on managing symptoms and trying to limit the progression of bone formation. High-dose corticosteroids are often used during the acute phase of a flare-up to reduce intense inflammation and tissue swelling. Non-steroidal anti-inflammatory drugs (NSAIDs) and other pain relievers are used to manage chronic pain. Recently, new targeted medications have been approved in some regions that specifically aim to inhibit the signaling pathways responsible for abnormal bone growth, offering the first potential therapies to alter the course of the disease. Effectiveness varies, and these treatments are generally prescribed under the guidance of a specialist.

Lifestyle and Supportive Care
Because surgery to remove the extra bone is not an option—the bone simply grows back more densely—lifestyle management is key. Strategies include:

• Fall prevention: Making the home environment safe to reduce the risk of injury.
• Dental care: Using specialized tools and non-invasive hygiene methods to maintain oral health without overextending the jaw.
• Respiratory health: Performing breathing exercises to maintain lung capacity as the chest wall becomes rigid.
• Adaptive devices: Using tools like reachers, custom shoes, and wheelchairs to maintain independence as mobility decreases.

When to Seek Medical Care
Patients should contact their healthcare provider immediately if they experience signs of a flare-up or injury. Red-flag situations include:

• Any fall or soft tissue injury, which requires immediate evaluation and potential preventative treatment.
• Sudden onset of red, painful, or warm swelling on the body.
• Difficulty breathing or signs of respiratory infection.
• Routine follow-up is essential to monitor disease progression, lung function, and to adjust care plans.

Severity and Disease Course
Fibrodysplasia ossificans progressiva is a severe and disabling condition. The disease course is characterized by episodic flare-ups that result in the cumulative loss of movement. While there may be periods of latency where no new bone forms, the disability is permanent and progressive. The "second skeleton" eventually bridges major joints, rendering them immobile. The severity varies among individuals, but most people with FOP will face significant physical limitations by their second or third decade of life, often requiring a wheelchair for mobility.

Complications and Long-term Effects
The most serious long-term complications arise from the restriction of the rib cage and jaw. Thoracic insufficiency syndrome occurs when the joints of the ribs fuse, preventing the chest from expanding fully during breathing. This increases the risk of pneumonia and heart failure, which are the leading causes of mortality. Fusion of the jaw (temporomandibular joint) can lead to severe difficulties with eating, resulting in malnutrition and dental issues. Hearing impairment is also a common associated feature.

Prognosis
Life expectancy is reduced compared to the general population, with the median survival often estimated around 56 years, though this can vary. Early diagnosis and the avoidance of harm (such as biopsies) can prevent unnecessary acceleration of the disease. Emerging treatments that target the underlying genetic pathway bring hope for stabilizing the condition and improving the long-term prognosis for younger generations.

Impact on Daily Activities
As the condition progresses, daily life requires significant adaptation. Tasks such as dressing, bathing, and eating become difficult as the arms and spine lose flexibility. Children may need assistance at school with mobility and safety, while adults often require modifications to their workspace or may need to transition to different types of employment. Despite physical limitations, many individuals with FOP attend school, pursue careers, and maintain active social lives through the use of assistive technology and strong support networks.

Mental and Emotional Health
Living with a progressive, visible, and rare condition can be isolating and emotionally taxing. Anxiety regarding falls and the unpredictability of flare-ups is common. Psychological support and connecting with patient advocacy groups are vital for coping with the emotional burden and finding community among others facing similar challenges.

Questions to Ask Your Healthcare Provider
To better understand the condition and manage care, consider asking these questions:

• What are the specific signs of a flare-up I should look for?
• How can I best protect my child from injuries at school?
• Are there new clinical trials or treatments available that I should consider?
• What constitutes an emergency for someone with this condition?
• How can we manage dental health safely without triggering a flare-up?
• What immunizations are safe, and how should they be administered?

Q: Is there any surgery to remove the extra bone?
A: No. Surgery to remove the heterotopic bone is contraindicated because the trauma of the surgery triggers the body to repair the site with even more dense bone formation, worsening the condition.

Q: Can people with this condition exercise?
A: Yes, but it must be low-impact. Gentle water exercises (hydrotherapy) are often recommended because the warm water supports the body and allows for movement without the risk of impact or high stress on the muscles.

Q: Is the condition contagious?
A: No, FOP is a genetic disorder and cannot be spread from person to person.

Q: Can a child with FOP get vaccines?
A: Yes, vaccination is important, but they should generally be given subcutaneously (under the skin) rather than intramuscularly (into the muscle) to avoid triggering a flare-up. Always consult a specialist before any injection.

Q: Will the bone growth ever stop on its own?
A: The tendency to form bone persists throughout life, although the rate of progression can vary. There is no natural "burnout" phase where the risk disappears completely, but periods of stability can occur.